EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

Nikita Wilson John iD, Caitlyn Dang iD, Nidhi Reddy iD, Calvin Chao iD, Karen J Ho, Bin Jiang iD

Advanced Healthcare Materials · 2025-03 · 14 (7)

DOI: 10.1002/adhm.202401056 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 31.01.2025. Verfasst von Nikita Wilson John und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Chicago, IL, 60208, USA. Hauptthemen laut MEDLINE: Neointima, Hyperplasia, Bioengineering. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neointimal hyperplasia, a pathological response to arterial interventions or injury, often leads to restenosis and recurrent narrowing or occlusion, particularly in the peripheral vasculature. Its prevalence and negative impact on the long‐term success of vascular interventions have driven extensive research aimed at better understanding the condition and developing effective therapies. This review provides a comprehensive overview of emerging bioengineering strategies for treating neointimal hyperplasia in peripheral vessels. These approaches include novel therapeutics and cell‐based technologies designed to promote re‐endothelialization, modulate vascular smooth muscle cell (VSMC) phenotype, reduce inflammation, scavenge reactive oxygen species (ROS), and enhance biomechanical compatibility between grafts and native vessels. Furthermore, advanced therapeutic delivery modalities are highlighted for their potential to achieve targeted, localized treatment at injury sites. This review also explores underrepresented therapeutic targets beyond traditional approaches, offering new opportunities for intervention. The multifaceted examination underscores the challenge of neointimal hyperplasia and presents a promising roadmap toward more effective treatments, ultimately aiming to improve patient outcomes after vascular interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeointimaHyperplasiaBioengineeringHumansAnimalsMyocytes, Smooth Muscle

Stichwörter der Autor:innen

arterial restenosisbioengineering approachescell‐based therapieslocalized drug deliveryneointimal hyperplasiavascular manipulation

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Chicago, IL, 60208, USA.
  • Department of Surgery, Northwestern University Feinberg School of Medicine, 303 E Superior St, Chicago, Chicago, IL, 60611, USA.

ORCID-Profile: Nikita Wilson John, Caitlyn Dang, Nidhi Reddy, Calvin Chao, Bin Jiang

Förderung

  • NIBIB NIH HHS

Zitieren

APA

Wilson John, N., Dang, C., Reddy, N., Chao, C., Ho, K. J., & Jiang, B. (2025). Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges. Advanced Healthcare Materials, 14(7). https://doi.org/10.1002/adhm.202401056

Vancouver

Wilson John N, Dang C, Reddy N, Chao C, Ho KJ, Jiang B. Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges. Advanced Healthcare Materials. 2025;14(7). doi:10.1002/adhm.202401056

BibTeX
@article{WilsonJohn2025,
  author = {Wilson John, Nikita and Dang, Caitlyn and Reddy, Nidhi and Chao, Calvin and Ho, Karen J and Jiang, Bin},
  title = {Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {7},
  doi = {10.1002/adhm.202401056}
}
Kostenlos starten →